Four Firms Guide Pfizer's Latest Big Drug Buy

, The Am Law Daily

   | 0 Comments

Wachtell, Ropes & Gray, Davis Polk and Cooley are advising on a $14 billion deal that will see pharmaceutical giant Pfizer Inc. acquire cancer drug maker Medivation Inc.

This premium content is reserved for American Lawyer subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202765725043

Thank you!

This article's comments will be reviewed.